Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2005
06/29/2005EP1546169A2 Triplex hairpin ribozyme
06/29/2005EP1545638A1 Controlled release therapeutic wound dressings
06/29/2005EP1545636A1 Hemostatic dressing
06/29/2005EP1545624A2 Compositions for dna mediated gene silencing
06/29/2005EP1545622A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof
06/29/2005EP1545620A1 Pharmaceutical compositions comprising cyclosporin for oral administration
06/29/2005EP1545616A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer
06/29/2005EP1545610A2 Epitope sequences
06/29/2005EP1545608A2 Mammalian ch1 deleted mimetibodies, compositions, methods and uses
06/29/2005EP1545607A1 Allergy vaccines
06/29/2005EP1545604A2 Use of mullerian inhibiting substance and interferon for treating tumors
06/29/2005EP1545603A2 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
06/29/2005EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4
06/29/2005EP1545600A2 Protein and peptide expression for passive immunity
06/29/2005EP1545595A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
06/29/2005EP1545591A2 Therapeutic use for lp229, in particular for wound healing
06/29/2005EP1545590A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit
06/29/2005EP1545589A1 A method of modulating endothelial cell activity
06/29/2005EP1545588A2 Methods and compositions for activating or inhibiting vegf-d and vegf-c
06/29/2005EP1545587A1 Lactoferrin compositions and methods of wound treatment
06/29/2005EP1545585A1 Zinc transporter compositions for the treatment of cardiovascular diseases
06/29/2005EP1545584A2 Method for reducing morbidity and mortality in critically ill patients
06/29/2005EP1545583A1 Methods and preparations for curing critically ill patients
06/29/2005EP1545581A1 Peptides and related molecules that modulate nerve growth factor activity
06/29/2005EP1545580A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides
06/29/2005EP1545579A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
06/29/2005EP1545578A2 Compositions and methods for treating cardiovascular disease
06/29/2005EP1545577A2 Igf-binding protein-derived peptide or small molecule
06/29/2005EP1545576A2 Methods of using non-human animal apoliprotein a-i protein
06/29/2005EP1545575A2 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
06/29/2005EP1545574A2 Method of purifying polypeptides by simulated moving bed chromatography
06/29/2005EP1545573A2 Asialo-interferons and the treatment of liver cancer
06/29/2005EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
06/29/2005EP1545565A1 Methods and compositions for tissue regeneration
06/29/2005EP1545560A2 Inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases
06/29/2005EP1545557A2 Combination therapies with l-fmau for the treatment of hepatitis b virus infection
06/29/2005EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
06/29/2005EP1545554A1 Methods and compositions for treating diabetes mellitis
06/29/2005EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS
06/29/2005EP1545539A2 Compositions for inducing increased levels of bgr-chemokines and methods of use therefor
06/29/2005EP1545509A2 Caspase inhibitors as anticancer agents
06/29/2005EP1545482A1 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
06/29/2005EP1545475A1 Enteric composition for the manufacture of soft capsule wall
06/29/2005EP1545474A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
06/29/2005EP1545460A2 Insulin molecule having protracted time action
06/29/2005EP1545458A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
06/29/2005EP1545287A2 Vasoregulating compounds and methods of their use
06/29/2005EP1545207A2 Treatment of holocrine gland dysfunction with clostridia neurotoxins
06/29/2005EP1545204A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
06/29/2005EP1487826A4 NEW CRYSTALLINE FORMS OF (2S)-N-5-(AMINO(IMINO)METHYL)-2-THIENYLMETHYL-1-(2R)-2-((CARBOXYMETHYL)AMINO)-3,3-DIPHENYLPROPANOYL-2-PYRROLIDINECARBOXAMIDE.nH2O
06/29/2005EP1297186A4 Method of screening for chemotherapeutic treatments for cancer
06/29/2005EP1286679B8 Skin treatment preparation
06/29/2005EP1276505A4 Mixtures of triblock polyesterpolyethylene glycol copolymers
06/29/2005EP1272507B1 Integrin binding peptide derivatives
06/29/2005EP1239873B1 Use of fibrinolytic metalloproteinases for the therapeutic treatment of a blood clot
06/29/2005EP1172115B1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same
06/29/2005EP1165077B1 Viral treatment
06/29/2005EP1146861B1 Hydrogel particle formulations
06/29/2005EP1121425B1 Stabilized bioactive peptides and methods of identification, synthesis and use
06/29/2005EP1119625B1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
06/29/2005EP1025216B1 Transgenic animal models for cardiac hypertrophy and uses thereof
06/29/2005EP0954326B1 A process for viral inactivation of lyophilized blood proteins
06/29/2005EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
06/29/2005EP0862456B1 Hyaluronidase compositions for treating intravitreal hemorrhagic blood
06/29/2005EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof
06/29/2005CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same
06/29/2005CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof
06/29/2005CN1633448A Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/29/2005CN1633447A N-formyl peptide receptor complex with a G-protein kinase signal pathway modification agent
06/29/2005CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
06/29/2005CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof
06/29/2005CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/29/2005CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
06/29/2005CN1633309A Method of radio-labelling biomolecules
06/29/2005CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
06/29/2005CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor
06/29/2005CN1632118A Biology function of human nervous specific expression gene BRI3
06/29/2005CN1632116A Enhancement of virus-mediated DNA transfer
06/29/2005CN1632109A Highly expressed recombinant gutted adenovirus containing human constant region whole antibody gene and its use
06/29/2005CN1631900A Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component
06/29/2005CN1631898A Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof
06/29/2005CN1631896A Recombinant protein
06/29/2005CN1631437A Method for extracting and synthesizing thymus microcapsule sustained release needle by PLGA
06/29/2005CN1631436A Method for extracting and synthesizing alpha -2b microcapsule sustained release needle by PLGA
06/29/2005CN1631435A PEGlyated Chinese trichosannthes root protein medicine and its preparation
06/29/2005CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
06/29/2005CN1208346C Blood substitute prepared by hematoglobin-human seralbumin conjugate and its preparation method
06/29/2005CN1208344C Novel human cell endocytic regulatory protein, its coding sequence and use
06/29/2005CN1208343C Trichosanthin mutant
06/29/2005CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
06/29/2005CN1208088C Medicinal compositions for preventing and treating hemorrhagic diseases associating with thrombopathy
06/29/2005CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
06/29/2005CN1208065C Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs
06/29/2005CN1208055C Use of amino acids for making medicine for treating to insulin-resistance
06/28/2005US6911537 Steroid and sensitive intracellular nuclear receptors as regulatory controls for gene transcription; metabolism regulation of physiologic homeostasis
06/28/2005US6911532 Vertebrate apoptosis gene: compositions and methods
06/28/2005US6911530 Haemopoietin receptor and genetic sequences encoding same
06/28/2005US6911528 Comprises cholesterol modification
06/28/2005US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
06/28/2005US6911525 Lipopeptides as antibacterial agents
1 ... 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 ... 3163